Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MANE
MANE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MANE News
Siren Acquires New Stake in Veradermics
3d ago
Fool
Veradermics Presents New Therapy at SCALE Conference
4d ago
Newsfilter
Veradermics Reports Q1 Net Loss of $27.2 Million Amid IPO Success
6d ago
seekingalpha
VDPHL01 Positioned to Be First FDA-Approved Oral Treatment for Hair Loss in Nearly 30 Years
6d ago
Newsfilter
Latest Developments in the Biotech Sector
Apr 30 2026
NASDAQ.COM
Veradermics Prices Upsized Public Offering at $100 per Share
Apr 30 2026
Newsfilter
U.S. Stocks Decline Amid Geopolitical Tensions and Earnings Strength
Apr 28 2026
Yahoo Finance
US Stocks Fluctuate Slightly, Tech Stocks Reach New All-Time Highs
Apr 27 2026
NASDAQ.COM
Veradermics Proposes Public Offering of 3.35 Million Shares
Apr 27 2026
seekingalpha
Veradermics Proposes Public Offering of 3.35 Million Shares
Apr 27 2026
Newsfilter
US Stocks Dip as Rising Oil Prices Pressure Markets
Apr 27 2026
NASDAQ.COM
Market Volatility Amid Rising Oil Prices
Apr 27 2026
NASDAQ.COM
Veradermics Reports Positive Phase 2/3 Trial Results for Hair Loss Drug
Apr 27 2026
NASDAQ.COM
Veradermics to Host Investor Call on Phase 2/3 Trial Results
Apr 26 2026
Newsfilter
Veradermics Reports Q4 2025 Financial Results
Mar 30 2026
seekingalpha
Veradermics Completes Key Clinical Trials for VDPHL01
Mar 30 2026
Newsfilter
Show More News
